APPB Applied Biosciences Corporation (CE)

Applied BioSciences Corp.

9701 Wilshire Blvd., Suite 1000

Beverly Hills, California 90212

December 24, 2018

VIA EDGAR

Securities and Exchange Commission 

Division of Corporation Finance 

100 F. Street, N.E. 

Washington, D.C. 20549

Ladies and Gentlemen,

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Applied BioSciences Corp., a Nevada corporation (the “Company”), hereby requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s Registration Statement on Form S-1 (File No. 333-228652), together with all exhibits and amendments thereto (the “Registration Statement”), originally filed with the Commission on December 3, 2018. The Company is requesting withdrawal of the Registration Statement on the grounds that such withdrawal is consistent with the public interest and the protection of investors as contemplated by paragraph (a) of Rule 477.

The Company does not wish to undertake the offering described in the Registration Statement and confirms that no securities have been sold in connection with the Registration Statement.

The Company requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the account of the Company for future use.

Should you have any questions regarding the withdrawal, please contact the Company’s legal counsel, Thomas Puzzo, Esq. at (206) 522-2256.

Applied Biosciences (CE) (USOTC:APPB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Applied Biosciences (CE) (USOTC:APPB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024